New cancer drug funded

Pharmac has announced it will fund a new medication for patients with a rare cancer.

The Government drug-buying agency said a number of patients with chronic myeloid leukaemia (CML) were not able to use the treatment currently available.

As of yesterday, cancer specialists have been authorised to prescribe dasatinib, a costly but necessary alternative, for those unable to use current CML drug imatinib.